Even though the disclaimer on most advertisements may scream, 'past performance is not an indicator of future results', consistent return is the best guide to pick the right manager
The GMO co-founder on why fund managers could perforce end up investing in emerging markets
Your definitive guide to India's best fund managers
Paul Singer on how China’s stock market crash may have larger implications than the U.S. subprime mortgage crisis
The founder of India's premier mutual fund tracking agency on why it's imperative to know who's managing your money
An extract from Reserve Bank of India's deputy governor, Subir Gokarn's address at the India investment Forum 2012
L&T Finance Holdings' chairman and managing director, YM Deosthalee is on a buying spree
The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
We sieve through the performance of fastest growing companies to present the ones that can sustain growth to justify their valuation
With attractive valuation and robust financials, Quess Corp seems like a perfect opportunity for investors to latch on to
In Ankleshwar, feisty MSMEs that survived the Chinese onslaught say that the fight against red tapism is harder
After making it big in seafood exports, this Kochi-based firm now wants to dominate local waters
By focusing on its strength in manufacturing lyophilized injectables, Gufic Biosciences has made a strong comeback and wants to aggressively push into the EU market next
Eveready is diversifying into the highly competitive confectionery and FMCG segments. Will its gamble pay off?
Unrelenting commitment towards process and sticking to his conviction have augured well for Invesco’s Taher Badshah
Promoter of the recently listed Advanced Enzyme Technologies jacks up holding
Mahindra Finance is tapping new segments to tackle the errant monsoon and fickle farm incomes
Jinesh Gopani's bold contrarian bets have paid off and he plans to hold onto them
Varun Berry is busy experimenting with different strategies as he seeks to perfect the Britannia recipe
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
A shift in focus in the US and the EU has propelled the stock price of Aurobindo Pharma to an all-time high
What are the big risks facing the world in 2015 and how will they shape the economy?
How a bunch of private players are looking to plug a serious gap and create value in India’s agri supply chain
Backed by investors, logistics start-ups are cashing in on the e-tailing boom